Search alternatives:
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
921
Simulated effects of increased pCREB combined with decreased pCaMKIIα on bistability.
Published 2022“…<p>(A1) Modification of model. Increased basal phosphorylation of CREB <i>k</i><sub><i>basalp_creb</i></sub>, concurrent with decreased basal phosphorylation of CaMKIIα <i>k</i><sub><i>basalp_CaMKII</i></sub>, in the absence of the effects of MeCP2/HDAC2/Sin3a (red) ([<i>E</i><sub><i>comp</i></sub>] = 0; [<i>E</i><sub><i>MeCP2</i></sub>] = 0). …”
-
922
-
923
-
924
-
925
-
926
Example of skyline query for proteins.
Published 2024“…Molecular docking results between PPARG and EP300 with the ten active compounds showed a binding affinity value of ≤ -5.0 kcal/mol in all dockings, indicating strong binding. …”
-
927
Top 10 pathways with the lowest p-value.
Published 2024“…Molecular docking results between PPARG and EP300 with the ten active compounds showed a binding affinity value of ≤ -5.0 kcal/mol in all dockings, indicating strong binding. …”
-
928
Pseudocode of block-nested loop (BNL).
Published 2024“…Molecular docking results between PPARG and EP300 with the ten active compounds showed a binding affinity value of ≤ -5.0 kcal/mol in all dockings, indicating strong binding. …”
-
929
Top 10 gene ontologies with the lowest p-value.
Published 2024“…Molecular docking results between PPARG and EP300 with the ten active compounds showed a binding affinity value of ≤ -5.0 kcal/mol in all dockings, indicating strong binding. …”
-
930
-
931
-
932
-
933
m 6A RNA Methylation Decreases Atherosclerotic Vulnerable Plaque Through Inducing T Cells
Published 2023“…Conclusion: After successfully establishing a vascular parkinsonism rabbit model, m 6A RNA methylation can decrease Th cells and vulnerable atherosclerotic plaques.…”
-
934
-
935
-
936
-
937
-
938
Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study
Published 2016“…At 12 weeks of treatment with pitavastatin compared to placebo; mean [95% confidence interval (CI)] total cholesterol (TC) was 207 (187.3, 226.8) mg/dL vs 246.3 (226.5, 266) mg/dL (<i>p</i> <0.001); mean (95% CI) triglyceride (TG) was 351.3 (193.2, 509.4) mg/dL vs 279.1 (121, 437.2) mg/dL (<i>p</i> = 0.269); mean (95% CI) high density lipoprotein (HDL) was 45.3 (40.4, 50.2) mg/dL vs 44.2 (39.3, 49.1) mg/dL (<i>p</i> = 0.354); and mean (95% CI) low density lipoprotein (LDL) was 113.2 (100.4, 126) mg/dL vs 145.6 (132.8, 158.4) mg/dL (<i>p</i> <0.001). …”
-
939
-
940